Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Epidemiological comparison of three Myco­plasma pneumoniae pneumonia epidemics in a single hospital over 10 years

  • Kim, Eun-Kyung (Department of Pediatrics, The Catholic University of Korea College of Medicine) ;
  • Youn, You-Sook (Department of Pediatrics, The Catholic University of Korea College of Medicine) ;
  • Rhim, Jung-Woo (Department of Pediatrics, The Catholic University of Korea College of Medicine) ;
  • Shin, Myung-Seok (Department of Pediatrics, The Catholic University of Korea College of Medicine) ;
  • Kang, Jin-Han (Department of Pediatrics, The Catholic University of Korea College of Medicine) ;
  • Lee, Kyung-Yil (Department of Pediatrics, The Catholic University of Korea College of Medicine)
  • Received : 2014.08.08
  • Accepted : 2014.09.25
  • Published : 2015.05.10
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Mycoplasma pneumoniae (MP) pneumonia epidemics have occurred in 3- to 4-year cycles in Korea. We evaluated the epidemiologic characteristics of MP pneumonia in Daejeon, Korea, from 2003 to 2012. Methods: We retrospectively analyzed 779 medical records of children (0-15 years of old) with MP pneumonia admitted to our institution and compared the data from 3 recent epidemics. Results: In 779 patients, the mean age and male-to-female ratio were $5.0{\pm}2.2$ years and 1:1, and most cases were observed in autumn. There were three epidemics during the study period, in 2003, 2006-2007, and 2011. In our comparison of the three epidemics, we found no differences in mean age, the male-to-female ratio, hospital stay, or the rate of seroconverters during hospitalization. All three epidemics began in early summer and peaked in September 2003 and 2011 and in October 2006 and then gradually decreased until the next year's spring season, although the 2006 epidemic extended further into 2007. The peak age groups in the children in 2003 and 2006 were 3-6 year-olds (57.5% and 56%, respectively), but in the 2011 epidemic, the peak group was 1-4 year-olds (46.5%). The proportion of the <2 years of age group was 20%, 15.7% and 28.8%, and >10 years of age group was 5.2%, 13.8%, and 14.8% of total patients, respectively. Conclusion: MP pneumonia outbreaks occurred every 3-4 years. The pattern of 3 recent epidemics was similar in demographic characteristics and seasonality with some variations in each outbreak.

Keywords

References

  1. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956-73. https://doi.org/10.1111/j.1574-6976.2008.00129.x
  2. Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther 2008;6:509-21. https://doi.org/10.1586/14787210.6.4.509
  3. Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979;139:681-7. https://doi.org/10.1093/infdis/139.6.681
  4. Ponka A. Occurrence of serologically verified Mycoplasma pneumoniae infections in Finland and in Scandinavia in 1970-1977. Scand J Infect Dis 1980;12:27-31. https://doi.org/10.3109/inf.1980.12.issue-1.05
  5. Lind K, Benzon MW, Jensen JS, Clyde WA Jr. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol 1997;13:581-6. https://doi.org/10.1023/A:1007353121693
  6. Rastawicki W, Kaluzewski S, Jagielski M. Occurrence of serologically verified Mycoplasma pneumoniae infections in Poland in 1970-1995. Eur J Epidemiol 1998;14:37-40. https://doi.org/10.1023/A:1007431932087
  7. Hauksdottir GS, Love A, Sigurdardottir V, Jonsson T. Outbreaks of Mycoplasma pneumoniae infections in Iceland 1987 to 1997: a ten and a half years review. Eur J Epidemiol 1999;15:95-6. https://doi.org/10.1023/A:1007579017695
  8. Ito I, Ishida T, Osawa M, Arita M, Hashimoto T, Hongo T, et al. Culturally verified Mycoplasma pneumoniae pneumonia in Japan: a long-term observation from 1979-99. Epidemiol Infect 2001;127:365-7.
  9. Kang KS, Woo HO. Pattern of occurrence of Mycoplasma pneumoniae pneumonia in admitted children: Southern Central Korea, from 1989 to 2002. J Korean Pediatr Soc 2003;46:474-9.
  10. Kim JW, Seo HK, Yoo EG, Park SJ, Yoon SH, Jung HY, et al. Mycoplasma pneumoniae pneumonia in Korean children, from 1979 to 2006: a meta-analysis. Korean J Pediatr 2009;52:315-23. https://doi.org/10.3345/kjp.2009.52.3.315
  11. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect 2008;56:326-31. https://doi.org/10.1016/j.jinf.2008.02.018
  12. Lenglet A, Herrador Z, Magiorakos AP, Leitmeyer K, Coulombier D; European Working Group on Mycoplasma pneumoniae surveillance. Surveillance sta tus and recent data for Mycoplasma pneumoniae infections in the European Union and European Economic Area, January 2012. 2012;17:pii=20075.
  13. Othman N, Isaacs D, Kesson A. Mycoplasma pneumoniae infections in Australian children. J Paediatr Child Health 2005;41:671-6. https://doi.org/10.1111/j.1440-1754.2005.00757.x
  14. Defilippi A, Silvestri M, Tacchella A, Giacchino R, Melioli G, Di Marco E, et al. Epidemiology and clinical features of Mycoplasma pneumoniae infection in children. Respir Med 2008;102:1762-8. https://doi.org/10.1016/j.rmed.2008.06.022
  15. Gadsby NJ, Reynolds AJ, McMenamin J, Gunson RN, McDonagh S, Molyneaux PJ, et al. Increased reports of Mycoplasma pneumoniae from laboratories in Scotland in 2010 and 2011 - impact of the epidemic in infants. Euro Surveill 2012;17:pii=20110.
  16. Brunner H, Prescott B, Greenberg H, James WD, Horswood RL, Chanock RM. Unexpectedly high frequency of antibody to Mycoplasma pneumoniae in human sera as measured by sensitive techniques. J Infect Dis 1977;135:524-30. https://doi.org/10.1093/infdis/135.4.524
  17. Nir-Paz R, Michael-Gayego A, Ron M, Block C. Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection. Clin Microbiol Infect 2006;12:685-8. https://doi.org/10.1111/j.1469-0691.2006.01469.x
  18. Kenri T, Okazaki N, Yamazaki T, Narita M, Izumikawa K, Matsuoka M, et al. Genotyping analysis of Mycoplasma pneumoniae clinical strains in Japan between 1995 and 2005: type shift phenomenon of M. pneumoniae clinical strains. J Med Microbiol 2008;57(Pt 4):469-75. https://doi.org/10.1099/jmm.0.47634-0
  19. Pereyre S, Charron A, Hidalgo-Grass C, Touati A, Moses AE, Nir-Paz R, et al. The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel. PLoS One 2012;7:e38585. https://doi.org/10.1371/journal.pone.0038585
  20. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother 2010;16:78-86. https://doi.org/10.1007/s10156-009-0021-4
  21. Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010;51:189-94. https://doi.org/10.1086/653535
  22. Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis 2013;19:1281-4. https://doi.org/10.3201/eid1908.121455
  23. Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 2012;55:1642-9. https://doi.org/10.1093/cid/cis784
  24. Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, et al. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents Chemother 2013;57:2252-8. https://doi.org/10.1128/AAC.00048-13
  25. Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. J Antimicrob Chemother 2013;68:506-11. https://doi.org/10.1093/jac/dks457
  26. Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 2012;55:42-7. https://doi.org/10.3345/kjp.2012.55.2.42
  27. Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2006;41:263-8. https://doi.org/10.1002/ppul.20374
  28. Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, et al. Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia. BMC Pediatr 2010;10:48. https://doi.org/10.1186/1471-2431-10-48
  29. Dorigo-Zetsma JW, Wilbrink B, van der Nat H, Bartelds AI, Heijnen ML, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 2001;183:675-8. https://doi.org/10.1086/318529
  30. Raty R, Ronkko E, Kleemola M. Sample type is crucial to the diagnosis of Mycoplasma pneumoniae pneumonia by PCR. J Med Microbiol 2005;54(Pt 3):287-91. https://doi.org/10.1099/jmm.0.45888-0
  31. Zhang L, Zong ZY, Liu YB, Ye H, Lv XJ. PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res 2011;134:270-80.

Cited by

  1. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2 vol.53, pp.11, 2015, https://doi.org/10.1128/jcm.01983-15
  2. Molecular typing of Mycoplasma pneumoniae: where do we stand? vol.10, pp.11, 2015, https://doi.org/10.2217/fmb.15.96
  3. Mycoplasma pneumoniae Epidemiology in England and Wales: A National Perspective vol.7, pp.None, 2015, https://doi.org/10.3389/fmicb.2016.00157
  4. The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae vol.7, pp.None, 2015, https://doi.org/10.3389/fmicb.2016.00232
  5. Epidemiology of Mycoplasma pneumoniae Infections in Japan and Therapeutic Strategies for Macrolide-Resistant M. pneumoniae vol.7, pp.None, 2015, https://doi.org/10.3389/fmicb.2016.00693
  6. Seasonal Patterns of Asthma in Children and Adolescents Presenting at Emergency Departments in Korea vol.8, pp.3, 2015, https://doi.org/10.4168/aair.2016.8.3.223
  7. The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children vol.6, pp.None, 2015, https://doi.org/10.1038/srep39929
  8. Early Serologic Diagnosis of Mycoplasma pneumoniae Pneumonia: An Observational Study on Changes in Titers of Specific-IgM Antibodies and Cold Agglutinins vol.95, pp.19, 2015, https://doi.org/10.1097/md.0000000000003605
  9. Insights into the pathogenesis of Mycoplasma pneumoniae vol.14, pp.5, 2015, https://doi.org/10.3892/mmr.2016.5765
  10. Clinical features according to chest radiologic patterns of Mycoplasma pneumonia in children vol.33, pp.2, 2015, https://doi.org/10.12701/yujm.2016.33.2.98
  11. Macrolide Resistance and Its Impacts on M. Pneumoniae Pneumonia in Children: Comparison of Two Recent Epidemics in Korea vol.9, pp.4, 2017, https://doi.org/10.4168/aair.2017.9.4.340
  12. Extensive and Progressive Cerebral Infarction after Mycoplasma pneumoniae Infection vol.32, pp.2, 2017, https://doi.org/10.4266/kjccm.2016.00283
  13. Control of a Mycoplasma pneumoniae Outbreak in an Institutional Setting Using Azithromycin Prophylaxis vol.5, pp.None, 2015, https://doi.org/10.3389/fpubh.2017.00366
  14. Clinical characteristics ofMycoplasma pneumoniaepneumonia in Korean children during the recent 3 epidemics vol.5, pp.1, 2015, https://doi.org/10.4168/aard.2017.5.1.8
  15. Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children vol.60, pp.6, 2017, https://doi.org/10.3345/kjp.2017.60.6.167
  16. Mycoplasma pneumoniae from the Respiratory Tract and Beyond vol.30, pp.3, 2017, https://doi.org/10.1128/cmr.00114-16
  17. Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia vol.60, pp.8, 2015, https://doi.org/10.3345/kjp.2017.60.8.245
  18. Viral and bacterial upper respiratory tract infection in hospital health care workers over time and association with symptoms vol.17, pp.None, 2015, https://doi.org/10.1186/s12879-017-2649-5
  19. Treatment of community-acquired pneumonia in Korean children vol.5, pp.4, 2015, https://doi.org/10.4168/aard.2017.5.4.177
  20. Clinical analysis of risk factors in refractory mycoplasma pneumonia in children vol.6, pp.1, 2018, https://doi.org/10.4168/aard.2018.6.1.62
  21. Epidemiological characterization of respiratory tract infections caused by Mycoplasma pneumoniae during epidemic and post-epidemic periods in North China, from 2011 to 2016 vol.18, pp.None, 2018, https://doi.org/10.1186/s12879-018-3250-2
  22. Current usage and effects of steroids in the management of childhood mycoplasma pneumonia in a secondary hospital vol.6, pp.2, 2015, https://doi.org/10.4168/aard.2018.6.2.122
  23. Increased procalcitonin level is a risk factor for prolonged fever in children with Mycoplasma pneumonia vol.61, pp.8, 2015, https://doi.org/10.3345/kjp.2018.61.8.258
  24. The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014 vol.61, pp.9, 2015, https://doi.org/10.3345/kjp.2017.06100
  25. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive Mycoplasma pneumoniae Pneumonia in Children vol.33, pp.43, 2018, https://doi.org/10.3346/jkms.2018.33.e268
  26. Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital vol.12, pp.None, 2015, https://doi.org/10.2147/idr.s193076
  27. A Presumed Etiology of Kawasaki Disease Based on Epidemiological Comparison With Infectious or Immune-Mediated Diseases vol.7, pp.None, 2019, https://doi.org/10.3389/fped.2019.00202
  28. Hyperoside inhibits proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae vol.453, pp.1, 2015, https://doi.org/10.1007/s11010-018-3443-4
  29. Epidemiological relationship between Mycoplasma pneumoniae pneumonia and recurrent wheezing episode in children: an observational study at a single hospital in Korea vol.9, pp.4, 2015, https://doi.org/10.1136/bmjopen-2018-026461
  30. Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children vol.8, pp.5, 2019, https://doi.org/10.3390/jcm8050726
  31. Changes in clinical features in Henoch-Schönlein purpura during three decades: an observational study at a single hospital in Korea vol.38, pp.10, 2015, https://doi.org/10.1007/s10067-019-04628-9
  32. Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China vol.8, pp.1, 2015, https://doi.org/10.1186/s13756-019-0576-5
  33. Periodic Genotype Shifts in Clinically Prevalent Mycoplasma pneumoniae Strains in Japan vol.10, pp.None, 2015, https://doi.org/10.3389/fcimb.2020.00385
  34. 마행감석탕의 소아 마이코플라즈마 폐렴 치료에 대한 체계적 문헌 고찰 및 메타분석 vol.34, pp.2, 2015, https://doi.org/10.7778/jpkm.2020.34.2.90
  35. Immunopathogenesis of COVID-19 and early immunomodulators vol.63, pp.7, 2015, https://doi.org/10.3345/cep.2020.00759
  36. Molecular Characterization of Mycoplasma pneumoniae Isolates in the United States from 2012 to 2018 vol.58, pp.10, 2015, https://doi.org/10.1128/jcm.00710-20
  37. Viral and bacterial coinfection among hospitalized children with respiratory tract infections vol.48, pp.10, 2015, https://doi.org/10.1016/j.ajic.2020.01.013
  38. Expression of Serum miR-155 in Children with Mycoplasma pneumoniae Pneumonia and Its Role in Immunity to Mycoplasma pneumoniae vol.14, pp.None, 2015, https://doi.org/10.2147/idr.s273423
  39. Early Confirmation of Mycoplasma pneumoniae Infection by Two Short-Term Serologic IgM Examination vol.11, pp.2, 2015, https://doi.org/10.3390/diagnostics11020353
  40. Macrolide-Resistant and Macrolide-Sensitive Mycoplasma pneumoniae Pneumonia in Children Treated Using Early Corticosteroids vol.10, pp.6, 2015, https://doi.org/10.3390/jcm10061309
  41. Risk factors for delayed radiographic resolution in children with refractory Mycoplasma pneumoniae pneumonia vol.49, pp.5, 2015, https://doi.org/10.1177/03000605211015579
  42. Respiratory viral infections in the lower respiratory tract failure (Literature review) vol.13, pp.4, 2015, https://doi.org/10.22625/2072-6732-2021-13-4-5-13